BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Promethera Biosciences Announces Updates to its Board of Directors Charles L. Dimmler, III elected as new Chairman of the Board

  “We welcome Charles, Masaki and Reiko as highly accomplished pharma and life sciences industry leaders, who will help us expand our corporate, deal-making and product development strategies,” said John Tchelingerian, President & CEO of Promethera

  April 6, 2018

   · 

  5 min read
• MOLOGEN: Final Analysis of IMPULSE Study Confirms Topline Data with Positive Subgroup Results

  The study evaluated the efficacy and safety of lefitolimod in patients with extensive-stage small-cell lung cancer

  April 6, 2018

   · 

  4 min read
• Deals

  Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to U.S. FDA-Approved A-101 40% Topical Solution from Aclaris Therapeutics

  Transaction broadens Cipher’s Canadian dermatology portfolio with first and only prescription product for raised seborrheic keratosis.

  April 6, 2018

   · 

  9 min read
• Pharm Country

  Mylan Strengthens Its Capital Structure by Extending Its Debt Maturities with a Successful $1.5 Billion Bond Offering

  The Notes will be issued by Mylan Inc. and guaranteed by Mylan N.V., and Mylan intends to use the net proceeds from the offering to redeem $1.5 billion aggregate principal amount of outstanding notes due in 2018 and 2019.

  April 6, 2018

   · 

  5 min read
• Pharm Country

  Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)

  Received final approval from the U.S. Food and Drug Administration in late January.

  April 6, 2018

   · 

  9 min read
• Drug Development

  Incyte and Merck Provide Update on Phase 3 Study of Epacadostat in Combination with KEYTRUDA® (pembrolizumab) in Patients with Unresectable or Metastatic Melanoma

  The study did not meet the primary endpoint of improving progression-free survival in the overall population compared to KEYTRUDA monotherapy

  April 6, 2018

   · 

  27 min read
• Business

  MobileHelp® Healthcare Partners with American Well® to Deliver Expanded Telehealth Options for Consumer and Professional Healthcare Applications

  MobileHelp Healthcare will embed American Well’s consumer offering, Amwell®, into its MobileHelp Touch platform, giving users the capability to better manage their health through direct video or voice connection to healthcare providers in their state.

  April 6, 2018

   · 

  2 min read
• Biotech Beach

  Johnson & Johnson Vision Highlights New Data, Educational Resources and Support for the Ophthalmology Community at the 2018 ASCRS•ASOA Annual Meeting

  New data to show patient satisfaction and quality of vision outcomes in cataract surgery and laser refractive surgery (LASIK)

  April 6, 2018

   · 

  6 min read
• BioMidwest

  Swift Biosciences Launches Unique Dual Indexing Kits to Improve Multiplexed Next Generation Sequencing

  New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results

  April 6, 2018

   · 

  2 min read
• Biotech Beach

  Biocept to Webcast Presentation at the 7th Annual MicroCap Conference

  Company to also co-host roundtable discussion

  April 6, 2018

   · 

  1 min read